Novel multifunctional antibody approved for the treatment of breast cancer
Oncoimmunology
.
2013 Mar 1;2(3):e24567.
doi: 10.4161/onci.24567.
Authors
Domenico Mavilio
1
,
Lorenzo Galluzzi
,
Enrico Lugli
Affiliation
1
Unit of Clinical and Experimental Immunology, Humanitas Clinical and Research Center; Rozzano, Italy.
PMID:
23802090
PMCID:
PMC3661175
DOI:
10.4161/onci.24567
No abstract available
Keywords:
T-DM1; breast carcinoma; cancer immunotherapy; monoclonal antibodies; trastuzumab.